Does PEMIGATINIB Cause Decreased appetite? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Decreased appetite have been filed in association with PEMIGATINIB (PEMAZYRE). This represents 4.8% of all adverse event reports for PEMIGATINIB.
34
Reports of Decreased appetite with PEMIGATINIB
4.8%
of all PEMIGATINIB reports
3
Deaths
5
Hospitalizations
How Dangerous Is Decreased appetite From PEMIGATINIB?
Of the 34 reports, 3 (8.8%) resulted in death, 5 (14.7%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for PEMIGATINIB.
What Other Side Effects Does PEMIGATINIB Cause?
Off label use (114)
Disease progression (103)
Death (76)
Fatigue (72)
Alopecia (53)
Hyperphosphataemia (46)
Cholangiocarcinoma (44)
Diarrhoea (42)
Constipation (37)
Drug ineffective (37)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which PEMIGATINIB Alternatives Have Lower Decreased appetite Risk?
PEMIGATINIB vs PENICILLAMINE
PEMIGATINIB vs PENICILLIN
PEMIGATINIB vs PENICILLIN G
PEMIGATINIB vs PENICILLIN G BENZATHINE
PEMIGATINIB vs PENICILLIN G PROCAINE